Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Dansk
English
!!Search content at Region Hovedstadens forskningsportal
Forside
Hospitaler/Afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Immune activation in multiple sclerosis and interferon-beta therapy
Martin Krakauer
Afdeling for Hjerne- og Nervesygdomme
100
Downloads (Pure)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Immune activation in multiple sclerosis and interferon-beta therapy'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Multiple Sclerosis
100%
Immune Activation
100%
Interferon-β Therapy
100%
Interleukin-23 (IL-23)
44%
Multiple Sclerosis Treatment
33%
Chemokine Receptor
33%
T Cells
33%
Interferon-beta (IFN-β)
33%
Disease Activity
22%
MRNA Expression
22%
Treatment Response
22%
Interleukin-10
22%
Chemokines
22%
T Helper Cells
22%
CXCL10
22%
Putative Biomarkers
22%
Early Effect
22%
CCR4
22%
Cytokine mRNA Expression
22%
Copenhagen
11%
Inflammatory Cytokines
11%
Healthy Controls
11%
Inflammatory Response
11%
Surrogate Marker
11%
Inflammation
11%
Active Disease
11%
Plasma Concentration
11%
Inflammatory Diseases
11%
Expression Pattern
11%
Mechanism of Action
11%
Disease Treatment
11%
Disease Severity
11%
Differentially Expressed
11%
Low Expression
11%
Cerebrospinal Fluid
11%
Late Effects
11%
Decreased Expression
11%
Blood Fluid
11%
Markers of Disease Severity
11%
Surface Expression
11%
C-C Chemokine Receptor Type 5 (CCR5)
11%
CD26
11%
Chemotactic Cytokines
11%
Acute Exacerbation
11%
Activation Markers
11%
CD4+ Lymphocytes
11%
Clinical Relapse
11%
Lymphoid Organs
11%
Apoptosis-related Proteins
11%
Th2 Cytokines
11%
Cytokine Secretion
11%
Lymphocyte Activation
11%
Effector Cells
11%
CCR7
11%
Dramatic Effect
11%
IL-10 Gene
11%
CXCR3
11%
PhD Dissertations
11%
Cytokine Expression Profile
11%
T Cell Immunology
11%
T Cell Recruitment
11%
Th1 Lymphocytes
11%
Th1 Effector Cells
11%
Treatment Lines
11%
T Helper 17 Cells (Th17)
11%
Disease Biomarkers
11%
Immunology and Microbiology
Multiple Sclerosis
100%
Beta Interferon
100%
T Cell
33%
Cytokine
25%
Chemokine
25%
Interleukin 10
25%
T Helper Cell
16%
CXCL10
16%
Chemokine Receptor
16%
Effector Cell
16%
Lymphocyte
16%
Blood Plasma
8%
Inflammation Response
8%
Proinflammatory Cytokine
8%
Cerebrospinal Fluid
8%
Inflammatory Disorder
8%
CD4
8%
Immunology
8%
Cytokine Release
8%
CCR5
8%
CCR4
8%
CXCR3
8%
Chemokine Receptor CCR4
8%
Lymphocyte Activation
8%
Programmed Cell Death
8%
Inflammation
8%
Neuroscience
Multiple Sclerosis
100%
Beta Interferon
100%
Messenger RNA
50%
T Cell
33%
Lymphocyte
33%
Cytokine
33%
Chemokine
25%
Interleukin 10
25%
CXCL10
16%
Chemokine Receptor
16%
Biological Marker
16%
Proinflammatory Cytokine
8%
CD4
8%
CCR5
8%
CCR4
8%
Blood Plasma
8%
Programmed Cell Death
8%
Chemokine Receptor CCR4
8%